Clinical Trial Detail

NCT ID NCT03166631
Title A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Boehringer Ingelheim
Indications

non-small cell lung carcinoma

Advanced Solid Tumor

Therapies

BI 754091 + BI 891065

BI 891065

Age Groups: adult senior

Additional content available in CKB BOOST